Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.
Analyst Ratings For Neurocrine Biosciences
Neurocrine Biosciences (NASDAQ:NBIX) has observed the following analyst ratings within the last quarter:
Craig-Hallum Downgrades PLAYSTUDIOS to Hold
Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.
Related Posts
Copy-Paste Hack? $190M Stolen From Coinbase-Backed Crypto Bridge Nomad
Over $190 million was drained from cross-chain cryptocurrency bridge Nomad on Monday in what is being described as one of the most perplexing hacks in DeFi history.
What Happened: On Aug. 1, market participants observed millions of dollars being drained from the Nomad contract address.
Asia Broadband Jumps on Cryptocurrency Adoption by Introducing AABBG in El Salvador
Developing countries lack sophisticated financial systems to manage their currencies and are turning to cryptocurrencies as a legal monetary tender. A leader in that movement is El Salvador, which this month passed a bill adopting Bitcoin (BTC) as the nation’s legal tender.
Keybanc Maintains Overweight on Coupa Software, Lowers Price Target to $100
Keybanc analyst Josh Beck maintains Coupa Software (NASDAQ:COUP) with a Overweight and lowers the price target from $125 to $100.